Adoptive cell therapy (ACT) is a highly effective and promising treatment method, which is generally activated by tumor-specific lymphocytes including TIL, CD8 + cells and CD4 + helper cells, or other cells of the immune system such as NK cells and DC cells, and then infused into patients to kill tumor cells. Here, CD8A is linked to neoplasm.